Search RFL
Rafael Holdings, Inc.
NYSE · CIK 1713863
Last close1.54
Daily change+0.04 (2.67%)
10 Years gain-68.13%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
RFL · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 0731
Fundamental
45.3Momentum
100.0Acceleration
100.0Confidence
82.0Annual Revenue10
Quarterly Revenue36
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth11.1 / 25
Quality18.2 / 25
Capital Efficiency1.6 / 20
Balance Sheet12.2 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 12243.3168 percentage points.
ROIC expansionROIC improved by 242.0311 percentage points.
Warnings
Heavy share dilution · HIGHDiluted share count increased 112.1288%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM40.51%OK
Revenue CAGR 3Y-58.17%OK
Gross Marginn/aMISSING
Operating Margin-2,981.75%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-70.86%OK
Incremental Operating Margin 3Y-1,920.06%OK
Net Debt / CFO1.23xOK
Diluted Share Growth 1Y112.13%OK
SBC / Revenue152.22%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Jul 31, 2025 | $30,000.00 | n/a | -$29.16M | -$18.92M | -$18.93M | n/a | -97,196.67% | -63,093.33% | -79.62% | 29.42M |
| 2025 FY Jul 31, 2024 | $637,000.00 | n/a | -$102.63M | -$7.80M | -$7.95M | n/a | -16,110.99% | -1,247.25% | -434.42% | 23.75M |
| 2024 FY Jul 31, 2023 | $279,000.00 | n/a | -$15.04M | -$10.89M | n/a | n/a | -5,391.76% | n/a | -40.73% | 23.26M |
| 2023 FY Jul 31, 2022 | $410,000.00 | n/a | -$60.48M | -$26.08M | -$26.08M | n/a | -14,750.49% | -6,361.22% | -62.98% | 19.77M |
| 2022 FY Jul 31, 2021 | $802,000.00 | -$2.37M | -$28.20M | -$15.60M | n/a | -295.14% | -3,516.08% | n/a | -19.8% | 16.52M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $992,000.00 | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-067560, 0001213900-25-120897 |
| Revenue Growth TTM | 40.51% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-067560, 0001213900-25-120897 |
| Revenue CAGR 3Y | -58.17% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-25-103549 |
| Revenue CAGR 5Y | -63.92% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-25-103549 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-067560, 0001213900-25-120897 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | -2,981.75% | Operating Income / Revenue | OK | 0001213900-26-067560, 0001213900-25-120897 |
| ROIC | -70.86% | NOPAT / Average Invested Capital | OK | 0001213900-26-067560, 0001213900-25-120897 |
| Net Debt / CFO | 1.23x | Net Debt / CFO | OK | 0001213900-26-067560, 0001213900-26-028348 |
| Current Ratio | 3.16x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 152.22% | SBC / Revenue | OK | 0001213900-26-067560, 0001213900-26-028348 |
| Revenue per Diluted Share | $0.02 | Revenue / Diluted Shares | OK | 0001213900-26-067560, 0001213900-25-120897 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | 0001213900-26-067560, 0001213900-26-028348 |